Nataliya Agafonova - Jan 2, 2024 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Chief Medical Officer
Signature
/s/ Paul Lehr, attorney-in-fact
Stock symbol
LGVN
Transactions as of
Jan 2, 2024
Transactions value $
-$4,058
Form type
4
Date filed
1/25/2024, 06:00 PM
Previous filing
Oct 4, 2023
Next filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Tax liability -$4.06K -3.07K -12.88% $1.32 20.8K Jan 2, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.
F2 Includes Restricted Stock Units subject to future vesting.